| IMDX Market Cap History Table | ||||||||||||
Below is a table of the IMDX market cap history going back to 5/5/2025:
Also see: IMDX Shares Outstanding History and IMDX YTD Return |
IMDX Market Cap History — Insight Molecular Diagnostics Capitalization Over Time
As of 5/4/2026 Insight Molecular Diagnostics has a market cap of 168.88 million. Investors often follow the IMDX market cap history to compare the size of the company over time.
This page shows IMDX market capitalization trends over time, with 5 market cap datapoints presented, dating back to 5/5/2025.
| IMDX Market Cap History Chart | |||||||||||||||
IMDX Historical Market Cap: +102.51% CAGR 
Mouse over chart for data details
| |||||||||||||||
| IMDX Stock Price Chart |
| About Insight Molecular Diagnostics Inc |
| Oncocyte Corporation is a precision diagnostics company. Co. is engaged in the development of Oncocytes tests and the acquisition of proprietary molecular technologies in the fields of oncology and transplantation. Co.'s products include DetermaIO, VitaGraft, DetermaCNI and GraftAssure. DetermaIO is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. DetermaIO measures the expression level of 27 selected genes, which are interpreted through the use of a proprietary algorithm (patent pending) which computes a quantitative score (IO Score) that incorporates information from the immune inflammatory infiltrates within and around the tumor. We show 5 historical shares outstanding datapoints in our IMDX shares outstanding history coverage, used to compute IMDX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing IMDX market cap history over the course of time is important for investors interested in comparing IMDX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of IMDX versus a peer is one thing; comparing IMDX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like IMDX can fluctuate over the course of history. With this page we aim to empower investors researching IMDX by allowing them to research the IMDX market cap history. |
| IMDX Current Stock Quote |
Quotes delayed 20 minutes  Free IMDX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| IMDX Share Performance |
| Market Cap Peers |
| Insight Molecular Diagnostics (IMDX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
IMDZ Market Cap History IMGN Market Cap History IMGO Market Cap History IMMU Market Cap History IMMX Market Cap History IMMY Market Cap History IMNM Market Cap History IMNN Market Cap History IMNP Market Cap History IMPL Market Cap History More Healthcare companies » |
IMDX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
